# ClinicalTrials.gov record NCT01394341

> PeptideScanner retained ClinicalTrials.gov record NCT01394341 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-10-09, and PeptideScanner's reviewed identity mapping was liraglutide.

- Evidence object: `story:clinicaltrials-gov-nct01394341-liraglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2013-10-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01394341-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01394341-liraglutide-v1.json
- Content SHA-256: `35075c10ab705d19b36d4b58cc1ac104bd1c0e022bdd27bd2bedad8fcca107a3`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01394341 ([`ctg-observation-nct01394341-2013-10-09-ca5621ff0462`](#source-ctg-observation-nct01394341-2013-10-09-ca5621ff0462))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01394341 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-10-09, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct01394341-2013-10-09-ca5621ff0462`](#source-ctg-observation-nct01394341-2013-10-09-ca5621ff0462))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01394341 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-10-09, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct01394341-2013-10-09-ca5621ff0462`](#source-ctg-observation-nct01394341-2013-10-09-ca5621ff0462))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01394341-2013-10-09-ca5621ff0462`](#source-ctg-observation-nct01394341-2013-10-09-ca5621ff0462))

## Sources

<a id="source-ctg-observation-nct01394341-2013-10-09-ca5621ff0462"></a>
- **ClinicalTrials.gov record NCT01394341 · retained source version 2013-10-09:ca5621ff0462e68b365da3604649f5e9c0b0e7bf1c5b364909b4cd8db2d2f8b6** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01394341) (`ctg-observation-nct01394341-2013-10-09-ca5621ff0462`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01394341." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01394341-liraglutide-v1.json SHA-256: 35075c10ab705d19b36d4b58cc1ac104bd1c0e022bdd27bd2bedad8fcca107a3.